Clinical trials
Phase 4 Liver Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
| Completed | 13 |
| Withdrawn | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 5 |
| RenJi Hospital | 2 |
| Uppsala University Hospital | 2 |
| Xu jianmin | 2 |
| Boston Scientific Corporation | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fox Chase Cancer Center | 1 |
| Fudan University | 1 |
| Helsinki University Central Hospital | 1 |
| Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 39 |
| Carcinoma, Hepatocellular | 16 |
| Kidney Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Hepatitis B | 3 |
| Lung Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.